Get the Stockscreener App
5.18
0.00%
0.00
After Hours:
5.28
0.10
+1.93%
Lexeo Therapeutics Inc stock is traded at $5.18, with a volume of 1.22M.
It is up +0.00% in the last 24 hours and up +10.92% over the past month.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
See More
Previous Close:
$5.18
Open:
$5.2
24h Volume:
1.22M
Relative Volume:
2.71
Market Cap:
$279.73M
Revenue:
-
Net Income/Loss:
$-86.60M
P/E Ratio:
-1.8288
EPS:
-2.8324
Net Cash Flow:
$-67.37M
1W Performance:
+3.19%
1M Performance:
+10.92%
6M Performance:
+78.01%
1Y Performance:
-47.52%
1-Day Range:
$4.90
$5.2499
1-Week Range:
$4.90
$5.40
52-Week Range:
$1.45
$11.72
Lexeo Therapeutics Inc Stock (LXEO) Company Profile
Name
Lexeo Therapeutics Inc
Sector
Industry
Phone
(212) 547-9879
Address
345 PARK AVENUE SOUTH, NEW YORK
Compare LXEO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LXEO
Lexeo Therapeutics Inc
|
5.18 | 280.81M | 0 | -86.60M | -67.37M | -2.8324 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-25 | Initiated | Oppenheimer | Outperform |
| Jun-13-24 | Initiated | Robert W. Baird | Outperform |
| Jun-06-24 | Initiated | H.C. Wainwright | Buy |
| Nov-28-23 | Initiated | Chardan Capital Markets | Buy |
| Nov-28-23 | Initiated | JP Morgan | Overweight |
| Nov-28-23 | Initiated | Leerink Partners | Outperform |
| Nov-28-23 | Initiated | RBC Capital Mkts | Outperform |
| Nov-28-23 | Initiated | Stifel | Buy |
View All
Lexeo Therapeutics Inc Stock (LXEO) Latest News
What moving averages say about Lexeo Therapeutics Inc.Watch List & Daily Stock Trend Watchlist - Newser
Is it time to cut losses on Lexeo Therapeutics Inc.July 2025 Trends & Community Consensus Picks - Newser
Market reaction to Lexeo Therapeutics Inc.’s recent newsJuly 2025 Action & Target Return Focused Picks - Newser
Can Lexeo Therapeutics Inc. hit a new high this monthMarket Risk Report & Reliable Entry Point Trade Alerts - Newser
Visualizing Lexeo Therapeutics Inc. stock with heatmaps2025 Buyback Activity & AI Enhanced Trading Alerts - Newser
Trend analysis for Lexeo Therapeutics Inc. this week2025 Price Targets & Long-Term Investment Growth Plans - Newser
How sentiment analysis helps forecast Lexeo Therapeutics Inc.Weekly Gains Summary & Free Technical Pattern Based Buy Signals - Newser
Ranking Lexeo Therapeutics Inc. among high performing stocks via toolsPortfolio Update Report & Risk Adjusted Swing Trade Ideas - Newser
How to recover losses in Lexeo Therapeutics Inc. stockMarket Sentiment Review & Weekly High Conviction Trade Ideas - Newser
Will Lexeo Therapeutics Inc. bounce back from current supportJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - Newser
What MACD signals say about Lexeo Therapeutics Inc.Trade Signal Summary & Safe Capital Investment Plans - Newser
What technical models suggest about Lexeo Therapeutics Inc.’s comebackQuarterly Profit Summary & Long-Term Safe Investment Ideas - Newser
Lexeo Therapeutics Inc. recovery potential after sell offJuly 2025 Update & Free Real-Time Market Sentiment Alerts - Newser
Visual trend scoring systems applied to Lexeo Therapeutics Inc.July 2025 Chart Watch & Daily Profit Maximizing Trade Tips - Newser
News impact scoring models applied to Lexeo Therapeutics Inc.Trade Risk Report & Fast Entry High Yield Stock Tips - Newser
What’s next for Lexeo Therapeutics Inc. stock priceWeekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - Newser
Lexeo Therapeutics, Inc. $LXEO Shares Sold by Adage Capital Partners GP L.L.C. - MarketBeat
How to track smart money flows in Lexeo Therapeutics Inc.Earnings Recap Report & Real-Time Volume Triggers - Newser
What is Lexeo Therapeutics Inc.’s book value per shareJuly 2025 Breakouts & Safe Entry Trade Signal Reports - Lancaster City Council
Vestal Point Capital LP Sells 63,751 Shares of Lexeo Therapeutics, Inc. $LXEO - MarketBeat
What are Lexeo Therapeutics Inc.’s recent SEC filings showing2025 Technical Overview & Weekly High Conviction Trade Ideas - خودرو بانک
Is Lexeo Therapeutics Inc. stock a value trapJuly 2025 Price Swings & Daily Momentum Trading Reports - خودرو بانک
How to manage a losing position in Lexeo Therapeutics Inc.Weekly Stock Report & Risk Managed Investment Strategies - Newser
Should value investors consider Lexeo Therapeutics Inc.2025 Earnings Impact & Daily Profit Focused Stock Screening - خودرو بانک
Real time alert setup for Lexeo Therapeutics Inc. performance2025 Market Overview & Precise Swing Trade Entry Alerts - Newser
How does Lexeo Therapeutics Inc. score in quality rankingsExit Point & Weekly Breakout Stock Alerts - خودرو بانک
Historical volatility pattern of Lexeo Therapeutics Inc. visualizedTrade Ideas & Weekly Hot Stock Watchlists - Newser
Will Lexeo Therapeutics Inc. rebound enough to break evenQuarterly Performance Summary & Accurate Technical Buy Alerts - Newser
Charles Schwab Investment Management Inc. Has $195,000 Position in Lexeo Therapeutics, Inc. $LXEO - Defense World
What’s the beta of Lexeo Therapeutics Inc. stockGlobal Markets & Free Long-Term Investment Growth Plans - 더경남뉴스
Backtesting results for Lexeo Therapeutics Inc. trading strategies2025 Major Catalysts & Weekly Sector Rotation Insights - Newser
What high frequency data says about Lexeo Therapeutics Inc.Quarterly Earnings Summary & Safe Entry Zone Identification - Newser
Identifying reversal signals in Lexeo Therapeutics Inc.Trade Risk Report & Weekly Top Gainers Trade List - Newser
Valuation Update: Is Lexeo Therapeutics Inc. still a buy after recent gainsJuly 2025 Catalysts & Reliable Volume Spike Trade Alerts - خودرو بانک
Can trapped investors hope for a rebound in Lexeo Therapeutics Inc.July 2025 Sector Moves & High Win Rate Trade Tips - Newser
Lexeo Therapeutics Inc. stock trend outlook and recovery pathMarket Trend Report & Fast Momentum Stock Entry Tips - Newser
Quantitative breakdown of Lexeo Therapeutics Inc. recent moveProduct Launch & Fast Exit/Entry Strategy Plans - Newser
Stifel Maintains Buy Rating on Lexeo Therapeutics (LXEO) - MSN
Price momentum metrics for Lexeo Therapeutics Inc. explainedFed Meeting & Risk Controlled Stock Pick Alerts - Newser
How does Lexeo Therapeutics Inc. compare to its peersJuly 2025 Selloffs & Smart Allocation Stock Reports - خودرو بانک
Institutional scanner results for Lexeo Therapeutics Inc.Portfolio Gains Summary & Fast Gain Swing Trade Alerts - Newser
Bear Alert: Is Lexeo Therapeutics Inc. affected by consumer sentimentProduct Launch & Weekly High Momentum Picks - خودرو بانک
What’s next for Lexeo Therapeutics Inc. stockJuly 2025 WrapUp & Smart Money Movement Tracker - خودرو بانک
Analyzing Lexeo Therapeutics Inc. with multi timeframe charts2025 Year in Review & Free Community Consensus Stock Picks - Newser
Is now the right time to enter Lexeo Therapeutics Inc.Weekly Investment Summary & Real-Time Market Sentiment Alerts - خودرو بانک
Lexeo Therapeutics Inc. stock momentum explainedGlobal Markets & AI Forecast for Swing Trade Picks - Newser
Lexeo Therapeutics Inc Stock (LXEO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):